Guys I saw on the Novartis ANN thread quite a few people referring to how the Type A REM-L meeting request was knocked back. Yet.....I can’t find any reference to that in any ANNs or news?
I know that REM-L was denied in a CRL from the FDA but then MSB said they would request a Type A meeting. And I’ve read a number of posts of people saying words to the effect of “it’s a shame about the Type A. Will msb release the notes or does today’s announcement admit defeat enough?”
and maybe I’m blind but I can find no such references to the Type A being rejected...?
AGM Discussion, page-21
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.39 |
Change
-0.075(5.12%) |
Mkt cap ! $1.587B | |||
| Open | High | Low | Value | Volume |
| $1.45 | $1.46 | $1.37 | $9.337M | 6.672M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 80200 | $1.39 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.40 | 28642 | 2 |
View Market Depth
| Last trade - 16.10pm 09/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |